Rhoclon 150mcg Injection

Rhoclone 150mcg Injection belongs to the class of medications called ‘immunising agents’ used to prevent rhesus disease. Rhesus factor type D (RhD) is a special characteristic of human red blood cells. People who carry the RhD factor are called RhD positive, and those who don’t carry the RhD factor are called RhD negative. Rhesus disease occurs if there are mixed blood types of RhD-positive and RhD-negative. It can happen in the case of a pregnant woman when the mother is RhD negative, and the baby is RhD positive and people who have received mismatched transfusion ((RhD negative child or adult who have accidentally received RhD positive blood). Rhoclone 150mcg Injection contains ‘Anti-D (Rh) immunoglobulin’, an immunising agent. Immunoglobulins or antibodies are essential to the immune response and help by protecting against viruses to prevent infection. Rhoclone 150mcg Injection works by neutralising the RhD-positive antigens that may have entered an RhD-negative person’s blood. Rhoclone 150mcg Injection is not recommended for use in positive RhD patients and individuals already immunised to RhD antigen.

rhoclon 150mcg injection  (RhIg) can be administered through two primary routes: intramuscular (IM) injection and intravenous (IV) injection. The doctor chooses the administration route based on the patient's needs and preferences.

rhoclon 150mcgInjection is an immunoglobulin (also known as antibody). It helps in preventing antibodies from forming after a person with Rh-negative blood receives a transfusion with Rh-positive blood. It also helps during pregnancy when a mother has Rh-negative blood and the baby is Rh-positive. It is administered routinely during the third trimester of your pregnancy if your blood type is RhD negative. This is because it's likely that small amounts of blood from your baby will pass into your blood during this time. It is to be administered only by or under the supervision of your doctor.

COLD CHAIN

1 VIAL